Download image:

Ariane van der Straten

Senior Fellow, Director, Women’s Global Health Imperative

Ariane van der Straten, PhD, is an expert in female-initiated HIV-prevention methods. Her research focuses on acceptability and adherence to new biomedical HIV-prevention methods and multipurpose technologies for contraception and HIV prevention.

She has led or participated in the development and implementation of major research projects in Africa and the U.S., including clinical trials of diaphragm and gel, oral, and vagina Tenofovir-based pre-exposure prophylaxis and vaginal rings. Dr. van der Straten has also led several studies focusing on adherence-related issues in the context of prevention trials.

Currently, she is working on a large multidisciplinary project to develop and test the use of a long-lasting, injectable, biodegradable, HIV-prevention device.

In addition, Dr. van der Straten serves as an associate professor at the University of California, San Francisco.


MPH, Public Health, The Johns Hopkins University, School of Hygiene and Public Health; PhD, Zoology (summa cum laude), University of Brussels, Laboratory of Genetics; BS (summa cum laude), Zoology-Molecular Biology, University of Louvain, Belgium.

Latest Publications

Noguchi, L.M., Richardson, B.A., Baeten, J.M., Hillier, S.L., Balkus, J.E., Chirenje, Z.M., Bunge, K., Ramjee, G., Nair, G., Palanee-Phillips, T., Selepe, P., van der Straten, A., et al. (2015). Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV, 2 (7):e279-e287.
Marrazzo, J.M., Ramjee, G., Richardson, B.A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., et al. (2015). Tenofovir-based preexposure prophylaxis for HIV infection among African women. Obstetrical & Gynecological Survey, 70 (7):444-446.
Palanee-Phillips, T., Schwartz, K., Brown, E.R., Govender, V., Mgodi, N., Kiweewa, F.M., Nair, G., Mhlanga, F., Siva, S., Bekker, L.G., Jeenarain, N., Gaffoor, Z., Martinson, F., Makanani, B., Naidoo, S., Pather, A., Phillip, J., Husnik, M.J., van der Straten, A., et al. (2015). Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention. PLoS one, 10 (6):e0128857.
Chen, B.A., Panther, L., Marzinke, M.A., Hendrix, C.W., Hoesley, C.J., van der Straten, A., et al. (2015). Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: a Double-Blind Randomized Trial. Journal of Acquired Immune Deficiency Syndromes, Advance Online Publication .
Minnis, A.M., van der Straten, A., Salee, P., & Hendrix, C.W. (2015). Pre-exposure Prophylaxis Adherence Measured by Plasma Drug Level in MTN-001: Comparison Between Vaginal Gel and Oral Tablets in Two Geographic Regions. AIDS and Behavior, Advance Online Publication .
View all publications by Ariane van der Straten (128)


  • Female-Initiated HIV Prevention Methods: Microbicides, Barrier Methods, and PrEP
  • Acceptability, Adherence, and Their Measurement
  • Clinical Trials
  • Qualitative and Quantitative Research Methods